MX2020001481A - Novedosos compuestos que activan la ruta nrf2. - Google Patents

Novedosos compuestos que activan la ruta nrf2.

Info

Publication number
MX2020001481A
MX2020001481A MX2020001481A MX2020001481A MX2020001481A MX 2020001481 A MX2020001481 A MX 2020001481A MX 2020001481 A MX2020001481 A MX 2020001481A MX 2020001481 A MX2020001481 A MX 2020001481A MX 2020001481 A MX2020001481 A MX 2020001481A
Authority
MX
Mexico
Prior art keywords
novel compounds
nrf2 pathway
sup
sub
compounds activating
Prior art date
Application number
MX2020001481A
Other languages
English (en)
Inventor
Puig Duran Carlos
Albericio Palomera Fernando
Gongora Benitez Miriam
Paradis Bas Marta
Ramos Tomillero Ivan
Fiacco Stephen
Davis Andrew
Geschwindner Stefan
Brun Cubero Omar
Heras Paniagus Carlos
Trallero Canela Nuria
Miret Casals Laia
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of MX2020001481A publication Critical patent/MX2020001481A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a compuestos peptídicos, cuyos compuestos peptídicos son compuestos de fórmula (I)', o una sal, o solvato, o N-óxido, o estereoisómero farmacéuticamente aceptable del mismo: (ver Fórmula) en la que R1; R2; s; t; u; Aa78 y G1 son como se han definido en el presente documento. Los compuestos peptídicos son útiles para activar la ruta Nrf2.
MX2020001481A 2017-08-08 2018-08-08 Novedosos compuestos que activan la ruta nrf2. MX2020001481A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382558 2017-08-08
PCT/EP2018/071536 WO2019030298A1 (en) 2017-08-08 2018-08-08 NEW COMPOUNDS THAT ACTIVATE THE NRF2 PATH

Publications (1)

Publication Number Publication Date
MX2020001481A true MX2020001481A (es) 2020-03-20

Family

ID=59677167

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020001481A MX2020001481A (es) 2017-08-08 2018-08-08 Novedosos compuestos que activan la ruta nrf2.

Country Status (24)

Country Link
US (1) US20200255478A1 (es)
EP (1) EP3665182A1 (es)
JP (1) JP2020530022A (es)
KR (1) KR20200035269A (es)
CN (1) CN110997695A (es)
AR (1) AR113100A1 (es)
AU (1) AU2018314833B2 (es)
BR (1) BR112019026306A2 (es)
CA (1) CA3066698A1 (es)
CL (1) CL2020000305A1 (es)
CO (1) CO2020000617A2 (es)
CR (1) CR20200056A (es)
DO (1) DOP2020000017A (es)
EA (1) EA202090432A1 (es)
EC (1) ECSP20008530A (es)
IL (1) IL272467A (es)
JO (1) JOP20200025A1 (es)
MA (1) MA49828A (es)
MX (1) MX2020001481A (es)
PE (1) PE20211460A1 (es)
PH (1) PH12019502852A1 (es)
SG (1) SG11201913161WA (es)
TW (1) TW201919682A (es)
WO (1) WO2019030298A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3242384A1 (en) * 2021-12-17 2023-06-22 3B Pharmaceuticals Gmbh Carbonic anhydrase ix ligands

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT7920688V0 (it) 1979-02-05 1979-02-05 Chiesi Paolo Parma Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore.
CY1492A (en) 1981-07-08 1990-02-16 Draco Ab Powder inhalator
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
FI69963C (fi) 1984-10-04 1986-09-12 Orion Yhtymae Oy Doseringsanordning
DE3927170A1 (de) 1989-08-17 1991-02-21 Boehringer Ingelheim Kg Inhalator
IT1237118B (it) 1989-10-27 1993-05-18 Miat Spa Inalatore multidose per farmaci in polvere.
US5201308A (en) 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
GB9015522D0 (en) 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
WO1992003175A1 (en) 1990-08-11 1992-03-05 Fisons Plc Inhalation device
DE4027391A1 (de) 1990-08-30 1992-03-12 Boehringer Ingelheim Kg Treibgasfreies inhalationsgeraet
DE69132850T2 (de) 1990-09-26 2002-05-29 Pharmachemie Bv Wirbelkammer-Pulverinhalator
GB9026025D0 (en) 1990-11-29 1991-01-16 Boehringer Ingelheim Kg Inhalation device
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
DE4239402A1 (de) 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
JP2924924B2 (ja) 1992-12-18 1999-07-26 シェリング・コーポレーション 粉末薬物のための吸入器
NZ306280A (en) 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler for salmeterol
ATE209518T1 (de) 1995-06-21 2001-12-15 Asta Medica Ag Arzneipulverkartusche mit integrierter dosiereinrichtung, sowie pulverinhalator
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
DK2351844T3 (da) 2003-04-29 2014-09-22 Sarepta Therapeutics Inc Præparater til forøgelse af transport- og antisense-effektivitet af nukleinsyreanalog i celler
CA2572790C (en) 2004-07-16 2014-12-23 Laboratorios Almirall, S.A. Inhaler for the administration of powdered pharmaceuticals, and a powder cartridge system for use with this inhaler
NZ578804A (en) 2007-02-28 2012-04-27 Leo Pharma As Spirocyclic phosphodiesterase inhibitors
US8575305B2 (en) 2008-06-04 2013-11-05 Medical Research Council Cell penetrating peptides
JP2012051826A (ja) * 2010-08-31 2012-03-15 Toray Ind Inc 環状ペプチド及びその修飾ペプチド並びにＫｅｌｃｈ様ＥＣＨ結合タンパク質１の結合阻害物質のスクリーニング方法
EP2704749A1 (en) 2011-05-05 2014-03-12 Sarepta Therapeutics, Inc. Peptide oligonucleotide conjugates
BR112014004902B1 (pt) 2011-08-30 2022-02-08 United Kingdom Research And Innovation Peptídeo, composição farmacêutica ou medicamento compreendendo o dito peptídeo e uso do mesmo para tratar distrofia muscular de duchenne
JP2015067579A (ja) * 2013-09-30 2015-04-13 国立大学法人東北大学 細胞透過性ペプチド及び当該ペプチドを含む医薬組成物。

Also Published As

Publication number Publication date
KR20200035269A (ko) 2020-04-02
CR20200056A (es) 2020-03-16
AU2018314833A1 (en) 2020-01-02
SG11201913161WA (en) 2020-01-30
ECSP20008530A (es) 2020-05-29
AU2018314833B2 (en) 2020-03-19
AR113100A1 (es) 2020-01-29
TW201919682A (zh) 2019-06-01
CL2020000305A1 (es) 2020-06-26
EP3665182A1 (en) 2020-06-17
CA3066698A1 (en) 2019-02-14
JOP20200025A1 (ar) 2020-02-04
BR112019026306A2 (pt) 2020-07-14
PE20211460A1 (es) 2021-08-05
CN110997695A (zh) 2020-04-10
MA49828A (fr) 2020-06-17
DOP2020000017A (es) 2020-02-28
EA202090432A1 (ru) 2020-06-08
IL272467A (en) 2020-03-31
JP2020530022A (ja) 2020-10-15
WO2019030298A1 (en) 2019-02-14
CO2020000617A2 (es) 2020-05-05
US20200255478A1 (en) 2020-08-13
PH12019502852A1 (en) 2020-09-28

Similar Documents

Publication Publication Date Title
SA520411222B1 (ar) مركبات بوصفها معدلات لعامل باديء حقيقي النواة 2ب وتركيبات وطرق
NZ747259A (en) Soluble c5ar antagonists
MX2019001096A (es) Antagonistas del receptor 7/8 tipo toll (tlr7/8) y uso de los mismos.
EP4248965A3 (en) Compounds, compositions and methods
JOP20180113A1 (ar) مركبات ,تركيبات وطرق
SG10201811384TA (en) Mnk inhibitors and methods related thereto
NZ730724A (en) Novel methyl-piperidine compounds useful for inhibiting microsomal prostaglandin e2 synthase-1
EP4248968A3 (en) Tlr7/8 antagonists and uses thereof
TN2018000106A1 (en) Farnesoid x receptor modulators
MX2020010674A (es) Agonistas del receptor muscarinico.
EP4316591A3 (en) Oxysterols and methods of use thereof
MA39956A (fr) Analogues du benzomorphane et leur utilisation
AU2018253590A1 (en) Imidazopyridazine compounds
MY192425A (en) Polymorphs
CR20220215A (es) Heteroaril bifenil amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1
SA518390920B1 (ar) مركبات فينوكسي أسيتاميد معالجة بإضافة حلقة
PH12019500822A1 (en) Crystalline forms of eravacycline
WO2018125880A8 (en) Nrf2 activator
JOP20200030A1 (ar) مركب خماسي الحلقة
TN2017000342A1 (en) Novel cyclopropabenzofuranyl pyridopyrazinediones
CR20200619A (es) Compuestos de cianotriazol y usos de los mismos
PH12019500370A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
MX2020001481A (es) Novedosos compuestos que activan la ruta nrf2.